Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

May 31, 2007

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Esomeprazole 40mg

DRUG

Pantoprazole 40mg

DRUG

Lansoprazole 30mg

Trial Locations (8)

Research Site, Anaheim

Research Site, Orange

Research Site, San Diego

Research Site, Miami

Research Site, Chicago

Research SIte, Chapel Hill

Research Site, Houston

Research Site, San Juan